Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaneck Biotech ETF (BBH)

Vaneck Biotech ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 587,446,500
  • Shares Outstanding, K 2,847
  • 60-Month Beta 0.90
Trade BBH with:
  • Price/Earnings ttm 29.78
  • Annual Dividend & Yield 0.61 (0.29%)
  • Most Recent Dividend 0.608 on 12/21/20
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 19.48%
  • Historical Volatility 18.56%
  • IV Percentile 12%
  • IV Rank 16.24%
  • IV High 34.87% on 10/30/20
  • IV Low 16.50% on 06/25/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 219
  • Open Int (30-Day) 309

Price Performance

See More
Period Period Low Period High Performance
1-Month
193.88 +6.76%
on 07/15/21
208.20 -0.58%
on 07/29/21
+5.32 (+2.64%)
since 06/30/21
3-Month
171.50 +20.69%
on 05/11/21
208.20 -0.58%
on 07/29/21
+18.22 (+9.65%)
since 04/30/21
52-Week
150.52 +37.52%
on 10/30/20
208.20 -0.58%
on 07/29/21
+39.00 (+23.21%)
since 07/30/20

Most Recent Stories

More News
Time for Pharma and Healthcare ETFs?

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

MRNA : 353.60 (+2.30%)
IYH : 285.97 (+0.03%)
BBH : 206.99 (+0.29%)
FXH : 122.05 (+0.26%)
IEIH : 35.78 (-0.48%)
2 Sector ETFs Hovering Around All-Time Highs

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

NETL : 31.72 (unch)
IYH : 285.97 (+0.03%)
BBH : 206.99 (+0.29%)
FXH : 122.05 (+0.26%)
RWR : 110.39 (-0.11%)
REZ : 90.04 (-0.10%)
NURE : 36.21 (-0.33%)
IEIH : 35.78 (-0.48%)
Moderna Soars on Inclusion to S&P 500: ETFs in Focus

Moderna, known for its success in the COVID-19 vaccine, has entered the big league with its addition to the S&P 500 Index.

ALXN : 182.50 (+1.70%)
IBB : 165.78 (-0.01%)
BBH : 206.99 (+0.29%)
GERM : 41.06 (+0.10%)
IBBQ : 25.82 (-0.31%)
Moderna ETFs to Rise on Positive COVID-19 Vaccine Updates

Moderna has once again come up with interesting updates about its COVID-19 vaccine.

AZN : 57.24 (-0.69%)
PFE : 42.81 (+0.05%)
MRNA : 353.60 (+2.30%)
IBB : 165.78 (-0.01%)
BBH : 206.99 (+0.29%)
IDNA : 50.11 (+0.16%)
GERM : 41.06 (+0.10%)
Biogen's Alzheimer's Drug Approval Puts Biotech ETFs in Spotlight

The FDA's approval of the first new drug to treat Alzheimer's disease in about 20 years has attracted investors' attention toward the biotech sector while sparking new controversies.

BIIB : 326.73 (-0.74%)
IBB : 165.78 (-0.01%)
XBI : 123.41 (-1.41%)
BBH : 206.99 (+0.29%)
FBT : 167.94 (-0.34%)
BTEC : 55.88 (-0.71%)
ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens

Moderna (MRNA) is once again in the spotlight with an impressive update relating to mRNA-1273.

MRNA : 353.60 (+2.30%)
IBB : 165.78 (-0.01%)
BBH : 206.99 (+0.29%)
IDNA : 50.11 (+0.16%)
GERM : 41.06 (+0.10%)
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

SNY : 51.56 (+0.06%)
AZN : 57.24 (-0.69%)
PFE : 42.81 (+0.05%)
MRNA : 353.60 (+2.30%)
IBB : 165.78 (-0.01%)
XBI : 123.41 (-1.41%)
BBH : 206.99 (+0.29%)
FBT : 167.94 (-0.34%)
BTEC : 55.88 (-0.71%)
BNTX : 328.35 (+5.04%)
CVAC : 49.26 (-5.01%)
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

JNJ : 172.20 (+0.01%)
AZN : 57.24 (-0.69%)
PFE : 42.81 (+0.05%)
MRNA : 353.60 (+2.30%)
IBB : 165.78 (-0.01%)
XBI : 123.41 (-1.41%)
BBH : 206.99 (+0.29%)
FBT : 167.94 (-0.34%)
BTEC : 55.88 (-0.71%)
How Will Biotech ETFs React to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 326.73 (-0.74%)
ALXN : 182.50 (+1.70%)
GILD : 68.29 (-2.21%)
AMGN : 241.54 (-0.38%)
IBB : 165.78 (-0.01%)
XBI : 123.41 (-1.41%)
BBH : 206.99 (+0.29%)
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

JNJ : 172.20 (+0.01%)
AZN : 57.24 (-0.69%)
NVAX : 179.33 (-2.54%)
IBB : 165.78 (-0.01%)
XBI : 123.41 (-1.41%)
BBH : 206.99 (+0.29%)
FBT : 167.94 (-0.34%)
BTEC : 55.88 (-0.71%)
OCGN : 6.71 (-1.61%)
IBRX : 10.96 (-2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

3rd Resistance Point 209.64
2nd Resistance Point 208.84
1st Resistance Point 207.92
Last Price 206.99
1st Support Level 206.20
2nd Support Level 205.40
3rd Support Level 204.48

See More

52-Week High 208.20
Last Price 206.99
Fibonacci 61.8% 186.17
Fibonacci 50% 179.36
Fibonacci 38.2% 172.55
52-Week Low 150.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar